CME
Income statement / Annual
Last year (2024), CME Group Inc.'s total revenue was $6.13 B,
an increase of 9.88% from the previous year.
In 2024, CME Group Inc.'s net income was $3.53 B.
See CME Group Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$6.13 B |
$5.58 B |
$5.02 B |
$4.69 B |
$4.88 B |
$4.87 B |
$4.31 B |
$3.64 B |
$3.60 B |
$3.33 B |
| Cost of Revenue |
$850.30 M
|
$828.60 M
|
$753.10 M
|
$837.00 M
|
$856.50 M
|
$898.70 M
|
$672.20 M
|
$563.90 M
|
$543.20 M
|
$581.50 M
|
| Gross Profit |
$5.28 B
|
$4.75 B
|
$4.27 B
|
$3.85 B
|
$4.03 B
|
$3.97 B
|
$3.64 B
|
$3.08 B
|
$3.05 B
|
$2.75 B
|
| Gross Profit Ratio |
0.86
|
0.85
|
0.85
|
0.82
|
0.82
|
0.82
|
0.84
|
0.84
|
0.84
|
0.83
|
| Research and Development Expenses |
$0.00
|
$218.70 M
|
$188.60 M
|
$192.60 M
|
$198.50 M
|
$201.50 M
|
$117.20 M
|
$101.60 M
|
$97.60 M
|
$0.00
|
| General & Administrative Expenses |
$132.70 M
|
$144.40 M
|
$137.40 M
|
$151.70 M
|
$191.30 M
|
$174.10 M
|
$453.90 M
|
$421.40 M
|
$437.70 M
|
$403.60 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$132.70 M
|
$144.40 M
|
$137.40 M
|
$151.70 M
|
$191.30 M
|
$174.10 M
|
$453.90 M
|
$421.40 M
|
$437.70 M
|
$403.60 M
|
| Other Expenses |
$1.22 B
|
$1.17 B
|
$1.11 B
|
$1.06 B
|
$1.20 B
|
$1.21 B
|
$575.70 M
|
$324.50 M
|
$387.00 M
|
$353.00 M
|
| Operating Expenses |
$1.35 B
|
$1.31 B
|
$1.25 B
|
$1.21 B
|
$1.39 B
|
$1.38 B
|
$1.03 B
|
$745.90 M
|
$824.70 M
|
$756.60 M
|
| Cost And Expenses |
$2.20 B
|
$2.14 B
|
$2.00 B
|
$2.04 B
|
$2.25 B
|
$2.28 B
|
$1.70 B
|
$1.33 B
|
$1.39 B
|
$1.34 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$160.90 M
|
$159.40 M
|
$162.70 M
|
$166.90 M
|
$166.20 M
|
$178.00 M
|
$157.70 M
|
$117.00 M
|
$123.50 M
|
$117.40 M
|
| Depreciation & Amortization |
$336.80 M
|
$352.60 M
|
$2.00 B
|
$2.04 B
|
$2.25 B
|
$2.28 B
|
$1.76 B
|
$1.33 B
|
$1.49 B
|
$129.20 M
|
| EBITDA |
$5.04 B |
$3.79 B |
$3.37 B |
$2.99 B |
$3.14 B |
$3.13 B |
$2.93 B |
$2.51 B |
$2.45 B |
$2.23 B |
| EBITDA Ratio |
0.82
|
0.68
|
0.63
|
0.6
|
0.57
|
0.56
|
0.63
|
0.67
|
0.65
|
0.64
|
| Operating Income Ratio |
0.64
|
0.62
|
0.6
|
0.56
|
0.54
|
0.53
|
0.61
|
0.63
|
0.61
|
0.6
|
| Total Other Income/Expenses Net |
$609.90 M
|
$717.90 M
|
$474.40 M
|
$728.40 M
|
$84.70 M
|
$101.80 M
|
$170.20 M
|
$215.70 M
|
$87.10 M
|
-$31.90 M
|
| Income Before Tax |
$4.54 B
|
$4.15 B
|
$3.49 B
|
$3.37 B
|
$2.72 B
|
$2.69 B
|
$2.78 B
|
$2.53 B
|
$2.29 B
|
$1.96 B
|
| Income Before Tax Ratio |
0.74
|
0.74
|
0.7
|
0.72
|
0.56
|
0.55
|
0.64
|
0.69
|
0.64
|
0.59
|
| Income Tax Expense |
$1.02 B
|
$927.40 M
|
$799.30 M
|
$736.70 M
|
$615.70 M
|
$573.80 M
|
$814.10 M
|
-$1.54 B
|
$753.50 M
|
$709.80 M
|
| Net Income |
$3.53 B
|
$3.23 B
|
$2.69 B
|
$2.64 B
|
$2.11 B
|
$2.12 B
|
$1.96 B
|
$4.06 B
|
$1.53 B
|
$1.25 B
|
| Net Income Ratio |
0.58
|
0.58
|
0.54
|
0.56
|
0.43
|
0.43
|
0.46
|
1.11
|
0.43
|
0.37
|
| EPS |
9.93 |
8.87 |
7.41 |
7.3 |
5.88 |
5.93 |
5.73 |
12 |
4.55 |
3.71 |
| EPS Diluted |
9.92 |
8.86 |
7.4 |
7.29 |
5.87 |
5.91 |
5.71 |
11.94 |
4.53 |
3.69 |
| Weighted Average Shares Out |
$359.39 M
|
$359.02 M
|
$358.71 M
|
$358.34 M
|
$357.76 M
|
$357.16 M
|
$342.34 M
|
$338.71 M
|
$337.50 M
|
$336.22 M
|
| Weighted Average Shares Out Diluted |
$359.94 M
|
$359.50 M
|
$359.18 M
|
$358.93 M
|
$358.52 M
|
$358.24 M
|
$343.74 M
|
$340.23 M
|
$338.97 M
|
$337.89 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
